准HSP90抑制STAT1/CCL8驱动的炎症,并减轻线粒体功能障碍,以减轻高血压引起的心房动
1College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China; State Key Laboratory of Frigid Zone Cardiovascular Disease, Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, China.
Life sciences
|February 20, 2026
概括
热冲击蛋白90 (HSP90) 通过促进线粒体功能障碍和炎症,驱动高血压诱导的心房动 (AF). 抑制HSP90同时减少了这些病理过程,为AF提供了潜在的治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 前庭动 (AF) 的发病过程涉及复杂的信号通路.
- 热冲击蛋白90 (HSP90) 已知对心血管有影响,但其在高血压引起的AF中的作用尚不清楚.
- 这项研究调查了HSP90在调控线粒体功能障碍和AF进展中的炎症中的作用.
研究的目的:
- 为了确定HSP90是否作为高血压引起的AF的主调节器.
- 阐明HSP90影响线粒体功能和炎症的机制.
- 评估AF中HSP90抑制的治疗潜力.
主要方法:
- 生物信息分析和在体内小鼠模型的AngII诱导的AF.
- 在体外研究中使用HL-1心房心肌细胞.
- 用于标识和评估HSP90抑制剂17AAG对AF诱导性,电生理学,纤维化,线粒体功能和炎症的影响的RNA测序.
主要成果:
- HSP90通过ERK酸化激活Dynamin相关蛋白1 (DRP1),导致过度的线粒体裂变和反应性氧物种的产生.
- HSP90稳定了转录因子STAT1,促进了化学因子CCL8的表达和巨细胞的招募,从而导致心房炎症.
- STAT1 knockdown 降低了CCL8上调和炎症级联.
结论:
- HSP90是高血压中AF的关键驱动因素,促进心律失常性心房基质.
- 通过协调ERK/DRP1介导的线粒体裂变和STAT1/CCL8驱动的炎症,HSP90促进AF.
- 抑制HSP90是一种有前途的肌肉增生疗法,为AF提供了预防和治疗的新机制基础.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
01:29Hypertension II: Pathophysiology
1.1K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.1K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.8K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.8K
01:26Atherosclerosis III: Management
473
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
473
01:30Heart Failure V: Medical Management
392
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
392
01:18Hypertension and Regulation of Blood Pressure
4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K